Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05039866 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Long-Term Follow-up of Subjects Who Were Treated With ST-920

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Enrollment reduced 33% 48 → 32 participants
See other at-risk trials from Sangamo Therapeutics

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment reduced: 48 → 32 participants
    • Trial status changed: Enrolling by Invitation → Active, Not Recruiting
    v11
  2. Study sites: 11 to 13v10
  3. Primary completion date: Jun 2028 to Mar 2029
    • Study sites: 9 to 11
    • Study completion date: Jun 2029 to Mar 2039
    v9
  4. Study sites: 7 to 9v8
  5. Study sites: 6 to 7v7
Show 5 earlier versionsHide 5 earlier versions
  1. Study sites: 5 to 6v6
  2. Study sites: 4 to 5
    • Eligibility criteria shortened, about 1 word
    v5
  3. Study sites: 3 to 4v4
  4. Study sites: 2 to 3v3
  5. Study sites: 1 to 2v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Long-term follow-up of subjects who received ST-920 in a previous trial (ST-920-201) and completed at least 52 weeks post-infusion follow-up in their primary protocol. Enrolled subjects will be followed for a total of up to 5 years following ST-920 infusion.
Trial Details
NCT Number NCT05039866
Lead Sponsor Sangamo Therapeutics
Conditions
(from sponsor)		 Fabry Disease, Fabry Disease, Cardiac Variant
Related terms Fabry Disease, Fabry Disease, Cardiac Variant
Enrollment 32 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov